A detailed history of Jackson Creek Investment Advisors LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Jackson Creek Investment Advisors LLC holds 54,833 shares of MYGN stock, worth $753,405. This represents 0.44% of its overall portfolio holdings.

Number of Shares
54,833
Holding current value
$753,405
% of portfolio
0.44%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$23.97 - $28.6 $1.31 Million - $1.57 Million
54,833 New
54,833 $1.5 Million
Q4 2021

Feb 01, 2022

SELL
$24.13 - $32.63 $794,287 - $1.07 Million
-32,917 Closed
0 $0
Q3 2021

Nov 02, 2021

BUY
$29.97 - $36.66 $986,522 - $1.21 Million
32,917 New
32,917 $1.06 Million

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.11B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Jackson Creek Investment Advisors LLC Portfolio

Follow Jackson Creek Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jackson Creek Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jackson Creek Investment Advisors LLC with notifications on news.